Vaxxinova is the developer and manufacturer of autogenous vaccines for veterinary use. Our autogenous vaccines are inactivated, mono- or polyvalent. In addition, combination of bacterial and viral antigen is also possible.
We use the latest diagnostic methods and production at GMP level, and benefit from the know-how of the international network of our group.
The aim of Vaxxinova is to offer highly-effective autogenous vaccines for each individual disease situation.